rs9402571 — SGK1
Regulatory variant in SGK1 (serum/glucocorticoid regulated kinase 1) — the minor G allele is associated with improved insulin secretion in lean individuals and a modest reduction in type 2 diabetes prevalence, while also modifying blood pressure response to high dietary salt intake.
Details
- Gene
- SGK1
- Chromosome
- 6
- Risk allele
- T
- Clinical
- Risk Factor
- Evidence
- Moderate
Population Frequency
Category
Blood Sugar & DiabetesSee your personal result for SGK1
Upload your DNA data to find out which genotype you carry and what it means for you.
Upload your DNA dataWorks with 23andMe, AncestryDNA, and other DNA test exports. Results in under 60 seconds.
SGK1 and the Insulin-Salt Axis: When Stress Hormones Shape Metabolism
SGK1 (serum/glucocorticoid regulated kinase 1) sits at a metabolic crossroads: it is switched on by two of the body's most powerful stress hormones — glucocorticoids such as cortisol and mineralocorticoids such as aldosterone — and it translates those signals into changes in ion channel activity, glucose transport, and cell survival. The rs9402571 variant lies in a regulatory region of the SGK1 gene, influencing how strongly SGK1 is expressed in response to hormonal cues. The common T allele provides less protection against T2D than the minor G allele, which was associated with improved beta-cell insulin secretion and a lower prevalence of type 2 diabetes in three independent European cohorts.
The Mechanism
SGK1 operates downstream of
PI3-kinase11 PI3-kinase
Phosphatidylinositol 3-kinase — a central node in the insulin and growth factor signaling network that activates both Akt and SGK1,
making it a functional sibling of
Akt (PKB)22 Akt (PKB)
Protein kinase B — the canonical insulin signaling effector that mediates glucose uptake, glycogen synthesis, and cell survival.
In pancreatic beta cells, SGK1 upregulation by glucocorticoids activates voltage-gated
K⁺ channels33 K⁺ channels
Potassium channels that repolarize the beta cell membrane after depolarization, terminating the calcium influx that triggers insulin release,
accelerating cellular repolarization and cutting calcium influx — the trigger for insulin
exocytosis. The consequence is reduced glucose-stimulated insulin release. This mechanism
was confirmed definitively44 was confirmed definitively
Ullrich et al. SGK1 mediates glucocorticoid-induced inhibition of insulin secretion. Diabetes, 2005
when SGK1 knockout mice showed complete resistance to dexamethasone-induced insulin
suppression, while wild-type mice showed clear reductions in stimulated insulin release.
SGK1 also directly regulates glucose uptake through
GLUT455 GLUT4
The insulin-responsive glucose transporter in muscle and adipose tissue that translocates to the cell membrane when insulin is present.
SGK1 phosphorylates GLUT4 at serine 274, promoting transporter trafficking to the plasma
membrane. This positions SGK1 as both a potential suppressor of insulin secretion (via
beta cells under glucocorticoid load) and a promoter of peripheral glucose uptake (via
GLUT4 in muscle and fat) — a dual role that may explain why its genetic variants influence
metabolic outcomes in a context-dependent way.
In the kidney and vasculature, SGK1 activates the
epithelial sodium channel (ENaC)66 epithelial sodium channel (ENaC)
The kidney's primary renal sodium reabsorption channel, the rate-limiter of salt retention and blood pressure
in response to aldosterone, driving sodium retention and blood pressure elevation. Variants
that alter SGK1 expression therefore alter the kidney's sensitivity to dietary salt.
The Evidence
The most direct evidence for rs9402571 comes from the
TUEF, EUGENE2, and METSIM studies77 TUEF, EUGENE2, and METSIM studies
Friedrich et al. Variance of the SGK1 gene is associated with insulin secretion in different European populations. PLoS One, 2008.
In the initial TUEF screening cohort (n=725), G allele carriers had significantly higher
C-peptide levels during a 2-hour oral glucose tolerance test (+10.8%, p=0.04) and higher
insulin-to-glucose AUC ratios. Replication in EUGENE2 (n=827) confirmed elevated insulin
secretion in lean G allele carriers (p=0.019). In the larger Finnish METSIM cohort
(n=3,798 non-diabetic, 659 T2D), G allele carriers showed a 15% lower T2D prevalence
(OR 0.85, 95% CI 0.71–1.01, p=0.065, dominant model) — a trend that reached borderline
significance. Crucially, the insulin secretion benefit was restricted to lean participants
(BMI ≤25), suggesting that metabolic context strongly modulates SGK1's genetic effect.
For salt sensitivity, the
Rao et al. 2013 study88 Rao et al. 2013 study
Rao et al. Polymorphisms in the SGK1 gene are associated with blood pressure and renin response to dietary salt intake. J Hum Hypertens, 2013
of 421 hypertensive Caucasians found that the major T allele (at rs9402571 and the related
rs2758151) was associated with higher systolic blood pressure on a high-salt diet and
decreased plasma renin activity on a low-salt diet — the classic fingerprint of salt-sensitive
hypertension mediated through SGK1's enhancement of renal sodium retention. Minor G allele
carriers were relatively protected from these salt-driven blood pressure excursions.
Practical Implications
For T allele homozygotes, the key actionable insights are:
Insulin secretion: The T allele lacks the enhanced beta-cell insulin response seen in G allele carriers, and is associated with higher baseline SGK1 activity under glucocorticoid stimulation. Chronic physiological or psychological stress raises cortisol, activates SGK1 in beta cells, and can progressively suppress insulin secretion — a mechanism that is especially relevant if stress levels are chronically elevated.
Salt sensitivity: T allele carriers show greater blood pressure excursions on high-sodium diets. Monitoring sodium intake and blood pressure response to dietary salt changes is genotype-specific advice that G allele homozygotes may not require to the same degree.
Interactions
The most important metabolic interaction involves chronic cortisol elevation from any source. Since SGK1 is a glucocorticoid-inducible kinase, the T allele's higher expression potential amplifies the beta-cell suppression caused by cortisol — a mechanism that connects chronic stress, sleep disruption, and exogenous glucocorticoid use to insulin secretion impairment in T allele carriers.
A related SGK1 variant, rs2758151 (also studied in the Rao et al. 2013 salt-sensitivity paper), is in linkage disequilibrium with rs9402571 and shows similar blood pressure associations. If both are carried on the same haplotype, the sodium-retention effect may be compounded.
Genotype Interpretations
What each possible genotype means for this variant:
Common SGK1 genotype — no protection from this variant
SGK1 is induced by glucocorticoids (cortisol) and mineralocorticoids (aldosterone). In pancreatic beta cells, SGK1 activates K⁺ channels that terminate insulin release. The T allele at rs9402571 is the baseline regulatory state — there is no added risk compared to the population average, but also no protective benefit. The clinically relevant implication is primarily around sodium sensitivity: if you have hypertension or a family history of hypertension, your SGK1 variant means high-salt diets are more likely to drive blood pressure increases than they would be in G allele carriers.
One protective G allele — improved insulin secretion and moderate salt resilience
The G allele's protective effect on insulin secretion appears mediated through regulatory effects on SGK1 expression — lower or differently timed SGK1 activity in beta cells may reduce the potassium channel-mediated braking of insulin release that SGK1 normally applies under glucocorticoid stimulation. The effect was most pronounced in lean individuals (BMI ≤25) in the published studies, suggesting the variant's benefit may be partially masked by obesity-related metabolic changes.
For blood pressure, the G allele appears to reduce SGK1's sodium-retaining activity in the kidney, making G carriers relatively less sensitive to high dietary salt.
Two protective G alleles — strongest insulin secretion benefit and lowest salt sensitivity
The double-G genotype represents the strongest expression of the protective SGK1 regulatory effect at this locus. In the mechanistic framework, lower or differently modulated SGK1 activity in beta cells means less glucocorticoid-driven braking of insulin secretion, and a more robust insulin response to glucose challenge. The GLUT4 phosphorylation arm of SGK1 activity may still function, supporting peripheral glucose uptake. The salt-resilience effect through reduced renal ENaC activation is also expected to be at its maximum in GG homozygotes.
The insulin secretion benefit was confirmed in three European cohorts (TUEF, EUGENE2, METSIM) and was specifically prominent in lean individuals — a finding that underscores the importance of maintaining leanness to express this genetic advantage.